(Q40843741)

24 September 2017

title

Ten-Year Mortality after Community-acquired Pneumonia. A Prospective Cohort (English)

1 reference

24 September 2017

0 references

Dean T Eurich

1

1 reference

24 September 2017

Thomas J Marrie

series ordinal

2

1 reference

24 September 2017

Jasjeet K Minhas-Sandhu

series ordinal

3

1 reference

24 September 2017

Sumit R Majumdar

series ordinal

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

11 June 2015

1 reference

American Journal of Respiratory and Critical Care Medicine

24 September 2017

published in

1 reference

24 September 2017

volume

192

1 reference

24 September 2017

issue

5

1 reference

24 September 2017

page(s)

597-604

1 reference

Patients with community acquired pneumonia discharged from the emergency department according to a clinical practice guideline

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

The burden of community-acquired pneumonia in seniors: results of a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

National trends in patient safety for four common conditions, 2005-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Outcomes and costs among seniors requiring hospitalization for community-acquired pneumonia in Alberta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Pneumonia: still the old man's friend?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Epidemiology and long-term clinical and biologic risk factors for pneumonia in community-dwelling older Americans: analysis of three cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Decrease in long-term survival for hospitalized patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Medium-term survival after hospitalization with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Population-based cohort study of outpatients with pneumonia: rationale, design and baseline characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Dysglycaemia and 90 day and 1 year risks of death or readmission in patients hospitalised for community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Ventilator-associated pneumonia and ICU mortality in severe ARDS patients ventilated according to a lung-protective strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Comorbidity measures for use with administrative data

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

Type 2 Diabetes and Pneumonia Outcomes: A population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0140OC

10.1164/RCCM.201501-0140OC

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference